Q1 Net Profit Jumps 22% YoY, Acquires 85% Stake in Aequitas Healthcare
Jagsonpal Pharmaceuticals Ltd · JAGSNPHARM · BSE ·
<b>Revenue from Operations:</b> Grew 8.76% YoY to ₹822.32 million for the quarter ended June 30, 2026. <b>Net Profit (PAT):</b> Increased by 22.18% YoY to ₹131.89 million. <b>Earnings Per Share (EPS):</b> Basic EPS stood at ₹2.00, a 25% increase from ₹1.60 in the same quarter las…